Baseline characteristics
| FGM group (n=49) | SMBG group (n=51) | P value | |
| Age (years) | 58.1 (9.8) | 58.7 (10.0) | 0.76 |
| Sex | |||
| Female | 15 (31%) | 17 (33%) | 0.48 |
| Male | 34 (69%) | 34 (67%) | |
| Body weight (kg) | 74.8 (22.1) | 71.3 (14.0) | 0.34 |
| Body mass index (kg/m2) | 27.5 (6.5) | 26.1 (4.1) | 0.22 |
| Blood pressure (mm Hg) | |||
| Systolic blood pressure | 134 (19) | 132 (13) | 0.64 |
| Diastolic blood pressure | 79 (12) | 80 (10) | 0.68 |
| HbA1c (%) | 7.83 (0.25) | 7.84 (0.27) | 0.75 |
| HbA1c (mmol/mol) | 62.1 (2.7) | 62.2 (2.9) | 0.75 |
| FPG (mg/dL) | 161 (40) | 159 (42) | 0.87 |
| Total cholesterol (mg/dL) | 191 (32) | 192 (42) | 0.95 |
| Triglyceride (mg/dL) | 155 (92) | 173 (146) | 0.47 |
| HDL cholesterol (mg/dL) | 54 (13) | 52 (13) | 0.49 |
| LDL cholesterol (mg/dL) | 110 (26) | 111 (36) | 0.93 |
| UA (mg/dL) | 5.3 (1.4) | 5.0 (1.1) | 0.39 |
| Cr (mg/dL) | 0.77 (0.20) | 0.75 (0.18) | 0.54 |
| Urinary albumin (mg/gCr) | 37 (56) | 103 (334) | 0.17 |
| AST (IU/L) | 26 (15) | 23 (9) | 0.18 |
| ALT (IU/L) | 34 (26) | 29 (19) | 0.29 |
| Use of antidiabetic drugs | 48 (98%) | 49 (97%) | 0.58 |
| Use of antihypertensive drugs | 23 (47%) | 24 (47%) | 0.99 |
| Use of lipid-lowering drugs | 31 (63%) | 29 (57%) | 0.51 |
Data are expressed as mean (SD) or n (%).
ALT, alanine aminotransferase; AST, aspartate aminotransferase; Cr, creatinine; FGM, flash glucose monitoring; FPG, fast plasma glucose; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SMBG, self-monitoring of blood glucose; UA, uric acid.